BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 29766398)

  • 21. 18F-FDG PET/CT in Hepatosplenic Gamma-Delta T-Cell Lymphoma.
    Quak E; Salaun V; Le Naoures C; Fruchart C
    Clin Nucl Med; 2015 Sep; 40(9):730-1. PubMed ID: 26053728
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study.
    Deepak P; Sifuentes H; Sherid M; Stobaugh D; Sadozai Y; Ehrenpreis ED
    Am J Gastroenterol; 2013 Jan; 108(1):99-105. PubMed ID: 23032984
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease].
    Saito A; Nara M; Fujishima T; Kuroki W; Yamashita T; Kobayashi T; Ikeda S; Kitadate A; Kameoka Y; Takahashi N
    Rinsho Ketsueki; 2024; 65(1):41-46. PubMed ID: 38311388
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hepatosplenic alphabeta T cell lymphoma.
    Nagai Y; Ikegame K; Mori M; Inoue D; Kimura T; Shimoji S; Togami K; Tabata S; Kurata M; Imai Y; Matsushita A; Nagai K; Ogawa H; Takahashi T
    Int J Clin Oncol; 2010 Apr; 15(2):215-9. PubMed ID: 20217452
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatosplenic T-cell lymphoma in a young immunocompetent man.
    Petrova M; Gomes MM; Carda JP; Pereira de Moura J
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 27033291
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Generalized Pyoderma Gangrenosum Associated with Ulcerative Colitis: Successful Treatment with Infliximab and Azathioprine.
    Chatzinasiou F; Polymeros D; Panagiotou M; Theodoropoulos K; Rigopoulos D
    Acta Dermatovenerol Croat; 2016 Apr; 24(1):83-5. PubMed ID: 27149138
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mixed-type autoimmune haemolytic anaemia: unusual cases and a case associated with splenic T-cell angioimmunoblastic non-Hodgkin's lymphoma.
    Win N; Tiwari D; Keevil VL; Needs M; Lakhani A
    Hematology; 2007 Apr; 12(2):159-62. PubMed ID: 17454198
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatosplenic T-cell lymphoma in patients receiving TNF-α inhibitor therapy: expanding the groups at risk.
    Parakkal D; Sifuentes H; Semer R; Ehrenpreis ED
    Eur J Gastroenterol Hepatol; 2011 Nov; 23(12):1150-6. PubMed ID: 21941193
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatosplenic T-cell Lymphoma: a review of clinicopathologic features, pathogenesis, and prognostic factors.
    Yabe M; Miranda RN; Medeiros LJ
    Hum Pathol; 2018 Apr; 74():5-16. PubMed ID: 29337025
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease.
    Mackey AC; Green L; Liang LC; Dinndorf P; Avigan M
    J Pediatr Gastroenterol Nutr; 2007 Feb; 44(2):265-7. PubMed ID: 17255842
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Fulminant liver failure induced by hepatosplenic alphabeta T-cell lymphoma.
    Petersen-Benz C; Hoffmann N; Beckurts T; Goeser T; Steffen HM; Dries V
    Z Gastroenterol; 2003 Nov; 41(11):1083-6. PubMed ID: 14648377
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hepatosplenic T-Cell Lymphoma in an Immunocompetent Male with Central Nervous System Invasion: A Rare Clinical Entity.
    Wu F; Pan Y; Wang H; Tao Q; An F; Zhang J; Zhai Z
    Cytometry B Clin Cytom; 2019 Nov; 96(6):475-479. PubMed ID: 30500103
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Expect the unexpected - Loss of surface CD3 on flow cytometry in hepatosplenic T-cell lymphoma: An eye opener.
    Chauhan R; Tyagi S; Mirgh S; Mishra P; Seth T; Mahapatra M; Pati H; Saxena R
    Indian J Pathol Microbiol; 2018; 61(2):275-277. PubMed ID: 29676377
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatosplenic T-cell lymphoma: a rare but challenging entity.
    Pro B; Allen P; Behdad A
    Blood; 2020 Oct; 136(18):2018-2026. PubMed ID: 32756940
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatosplenic αβ T-cell lymphoma arising after long-term azathioprine therapy successfully treated with allogeneic bone marrow transplant.
    Bašić Kinda S; Duraković N; Dotlić S; Serventi Seiwerth R; Davidović Mrsić S; Dubravčić K; Aurer I
    Leuk Lymphoma; 2013 Jun; 54(6):1334-5. PubMed ID: 23083012
    [No Abstract]   [Full Text] [Related]  

  • 36. A rare cause of Fever, hepatosplenomegaly, and thrombocytopenia: hepatosplenic gamma/delta T-cell lymphoma.
    Albayrak M; Balcik OS; Alan S; Dıncer SL; Yüksel MK; Albayrak A
    Pathol Oncol Res; 2011 Jun; 17(2):421-3. PubMed ID: 21197592
    [No Abstract]   [Full Text] [Related]  

  • 37. [26-year-old patient with ulcerative colitis and anemia].
    Kreth F; Neumann S; Hegenbart U; Mössner J; Caca K
    Internist (Berl); 2004 Feb; 45(2):217-20. PubMed ID: 14991164
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatosplenic T-cell lymphoma: A case series.
    Ashmore P; Patel M; Vaughan J; Wiggill T; Willem P; van den Berg E; Philip V; Lakha A
    Hematol Oncol Stem Cell Ther; 2015 Jun; 8(2):78-84. PubMed ID: 25450840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hepatosplenic T-cell lymphoma mimicking bone marrow metastasis.
    Benayoun E; Wagner-Ballon O
    Blood; 2015 Oct; 126(17):2071. PubMed ID: 26788568
    [No Abstract]   [Full Text] [Related]  

  • 40. Coexistent hairy cell leukaemia and hepatosplenic T-cell lymphoma: a case report.
    Gasljevic G; Kloboves-Prevodnik V; Gazic B; Vovk M
    Diagn Pathol; 2014 Mar; 9():58. PubMed ID: 24621139
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.